Delivery Order SPE2DB22D1017-SPE2DB25FE8SM

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,256.86 firm-fixed-price delivery order is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $5,387.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,358.09 delivery order contract is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication. The contract has a performance period through May 14, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,271.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of December 30, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,374.34, is a Firm Fixed Price Delivery Order for the supply of AMBIEN CR 6.25 MG TABLET 100S medical products. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,865.86, is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,358.09 for AMBIEN CR 12.5 MG TABLET 100S, with an ultimate completion date of January 9, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. In addition to this specific Delivery Order, AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,000.93 firm fixed-price delivery order is for AMBIEN CR 12.5 MG TABLET 100S and has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,572.06 firm fixed-price delivery order is for the supply of 4,568,188,741 units of the prescription medication Ambien CR 12.5 mg tablets. The contract has an ultimate completion date of May 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $2,279.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The award has an ultimate completion date of October 30, 2024 and is structured as a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen holds a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8SM
    Delivery Order

This federal contract award, valued at $7,437.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 2:00 PM